Back
Organon & Vs. Ligand Pharmaceuticals Industry Stock Comparison
Sell
22
OGN
Organon &
Last Price:
16.90
Seasonality Move:
11.37%
Buy
59
LGND
Ligand Pharmaceuticals
Last Price:
110.05
Seasonality Move:
12.9%
Sell
22
Organon & (OGN)
is a Sell
Is Organon & a Buy, Sell or Hold?
- The current Organon & [OGN] share price is $16.92. The Score for OGN is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
- OGN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
59
Ligand Pharmaceuticals (LGND)
is a Buy
Is Ligand Pharmaceuticals a Buy, Sell or Hold?
- The current Ligand Pharmaceuticals [LGND] share price is $110.15. The Score for LGND is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- LGND is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
LGND Stock Price Chart
What is Ligand Pharmaceuticals's stock price today?
-
The Ligand Pharmaceuticals share price today is $110.15
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LGND is experiencing buying pressure, which is a positive indicator for future bullish movement.
OGN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.4 | Sell |
| Relative Strength Index (14 RSI): | 35.34 | Sell |
| Chaikin Money Flow: | -3794008 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.4 - 18.48) | Sell |
| Bollinger Bands (100): | (18.54 - 21.52) | Sell |
LGND Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.1 | Buy |
| Relative Strength Index (14 RSI): | 56.31 | Buy |
| Chaikin Money Flow: | 52376 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (101.79 - 110.19) | Buy |
| Bollinger Bands (100): | (90.57 - 108.59) | Buy |
OGN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.67 | Sell |
| 20-day SMA: | 17.77 | Sell |
| 50-day SMA: | 19.37 | Sell |
| 200-day SMA: | 19.33 | Sell |
| 8-day EMA: | 17.7 | Sell |
| 20-day EMA: | 17.96 | Sell |
| 50-day EMA: | 18.83 | Sell |
| 200-day EMA: | 19.35 | Sell |
LGND Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 110.93 | Sell |
| 20-day SMA: | 107.05 | Buy |
| 50-day SMA: | 104.45 | Buy |
| 200-day SMA: | 88.21 | Buy |
| 8-day EMA: | 109.65 | Buy |
| 20-day EMA: | 107.7 | Buy |
| 50-day EMA: | 104.48 | Buy |
| 200-day EMA: | 91.25 | Buy |
Organon & Earnings Growth & OGN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.03 per share, and an increase next year of $0.20 per share.
Ligand Pharmaceuticals Earnings Growth & LGND Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.04 per share, and an increase next year of $0.84 per share.
Organon & Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ligand Pharmaceuticals Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||